These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 928283)

  • 21. Adrenal suppression following low-dose topical clobetasol propionate.
    Ohman EM; Rogers S; Meenan FO; McKenna TJ
    J R Soc Med; 1987 Jul; 80(7):422-4. PubMed ID: 3656312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guidelines for using superpotent topical steroids.
    Prawer SE; Katz HI
    Am Fam Physician; 1990 May; 41(5):1531-8. PubMed ID: 2333829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect on psoriasis of clobetasol propionate used alone or in combination with UVB.
    Larkö O; Swanbeck G; Svartholm H
    Acta Derm Venereol; 1984; 64(2):151-4. PubMed ID: 6203304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clobetasol propionate ointment once daily versus fluocinonide ointment three times daily in psoriasis.
    Bickers D; Cornell R; Kamm AR; Bauman WE; Handler RM; Medansky RS; Sturm HM
    Int J Dermatol; 1988; 27(1):54-5. PubMed ID: 3278991
    [No Abstract]   [Full Text] [Related]  

  • 25. Contact allergy to clobetasol propionate.
    Cox NH
    Arch Dermatol; 1988 Jun; 124(6):911-3. PubMed ID: 2967675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical experience with 0.05% clobetasol propionate creams.
    Richards RN
    J Am Acad Dermatol; 1985 May; 12(5 Pt 1):891-3. PubMed ID: 4008693
    [No Abstract]   [Full Text] [Related]  

  • 27. [Results of a multicenter double-blind study in patients with resistant psoriasis and atopic dermatitis. Diprolene ointment vs. Dermovate ointment].
    Blum G; Kröpfli P; Küng D; Suter H
    Ther Umsch; 1984 Jun; 41(6):420-4. PubMed ID: 6379974
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clobetasone butyrate, a topical steroid in geriatrics].
    Bonavita E; Bassi R; Mengoni M
    Clin Ter; 1985 Mar; 112(5):423-8. PubMed ID: 4017467
    [No Abstract]   [Full Text] [Related]  

  • 29. Clobetasol propionate for psoriasis: are ointments really more potent?
    Warino L; Balkrishnan R; Feldman SR
    J Drugs Dermatol; 2006 Jun; 5(6):527-32. PubMed ID: 16774104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of cyclosporine A and topical corticosteroid in the treatment of psoriasis.
    Griffiths CE; Powles AV; Baker BS; Fry L; Valdimarsson H
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):50-2. PubMed ID: 3381302
    [No Abstract]   [Full Text] [Related]  

  • 31. Superpotent topical steroid treatment of psoriasis vulgaris--clinical efficacy and adrenal function.
    Katz HI; Hien NT; Prawer SE; Mastbaum LI; Mooney JJ; Samson CR
    J Am Acad Dermatol; 1987 Apr; 16(4):804-11. PubMed ID: 3553247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of 0.25% zinc pyrithione spray does not enhance the efficacy of clobetasol propionate 0.05% foam in the treatment of psoriasis.
    Housman TS; Keil KA; Mellen BG; McCarty MA; Fleischer AB; Feldman SR
    J Am Acad Dermatol; 2003 Jul; 49(1):79-82. PubMed ID: 12833013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind comparison between a new trihalogenated dermatocorticosteroid (halometasone) cream and clobetasol 17-propionate (Dermovate) cream.
    Schwarz KJ; Konzelmann M; Yawalkar SJ; Schoenenberger PM
    Br J Clin Pract; 1982 May; 36(5):192-6. PubMed ID: 6756453
    [No Abstract]   [Full Text] [Related]  

  • 34. Topical application of clobetasol-17-propionate inhibits the intra-epidermal accumulation of polymorphonuclear leukocytes.
    Chang A; van de Kerkhof PC
    Acta Derm Venereol; 1988; 68(1):57-60. PubMed ID: 2449013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Contact dermatitis caused by creams containing clobetasol propionate].
    Camarasa JG; Serra-Baldrich E
    Med Cutan Ibero Lat Am; 1988; 16(4):328-30. PubMed ID: 3068444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anthralin-corticosteroid combination therapy in the treatment of chronic plaque psoriasis.
    Monk BE; Hehir ME; Clement MI; Pembroke AC; du Vivier A
    Arch Dermatol; 1988 Apr; 124(4):548-50. PubMed ID: 3355198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of two application schedules for clobetasol 17 propionate.
    vd Harst LC; de Jonge H; Pot F; Polano MK
    Acta Derm Venereol; 1982; 62(3):270-3. PubMed ID: 6179380
    [No Abstract]   [Full Text] [Related]  

  • 38. Short-term safety assessment of clobetasol propionate 0.05% shampoo: hypothalamic-pituitary-adrenal axis suppression, atrophogenicity, and ocular safety in subjects with scalp psoriasis.
    Andres P; Poncet M; Farzaneh S; Soto P
    J Drugs Dermatol; 2006 Apr; 5(4):328-32. PubMed ID: 16673799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clobetasol propionate shampoo 0.05% and calcipotriol solution 0.005%: a randomized comparison of efficacy and safety in subjects with scalp psoriasis.
    Reygagne P; Mrowietz U; Decroix J; de Waard-van der Spek FB; Acebes LO; Figueiredo A; Caputo R; Poncet M; Arsonnaud S
    J Dermatolog Treat; 2005 Feb; 16(1):31-6. PubMed ID: 15897165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Penile verrucous carcinoma.
    Yeager JK; Findlay RF; McAleer IM
    Arch Dermatol; 1990 Sep; 126(9):1208-10. PubMed ID: 2396837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.